Your Messages Inbox
Your Article Summary
See Latest ArticlesNabi Biopharmaceuticals Announces Withdrawal of Biotests Indemnification Claim
Nabi Biopharmaceuticals, 06/02/09
Nabi Biopharmaceuticals announced that Biotest Pharmaceuticals Corporation has withdrawn and released a claim representing $50.4 million of the original $56 million indemnification claims made on March 2009 against Nabi, and together with Nabi has instructed the escrow agent to release $4.5 million of the funds held in escrow to support indemnification claims. The withdrawn claim related to a contract assigned to Biotest when it purchased our biologics business unit in 2007.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Mandatory Disclosure of Pharmaceutical Industry-Funded Events for Health Professionals
PLoS Medicine, 12/02/09
FDA drug approval intervals from 1997 to 2006: analysis and comparison during information technology implementation
International Journal of Electronic Healthcare , 12/01/09
Regulatory Update: GSK files Rotarix for prevention of rotavirus in Japan
GlaxoSmithKline, 12/01/09
Article Search
Sponsor